Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patients
|
|
- Penelope Harper
- 5 years ago
- Views:
Transcription
1 Blackwell Science, LtdOxford, UKPCNPsychiatry and Clinical Neurosciences Blackwell Publishing Pty Ltd Original ArticleDementia and mild AlzheimersJ. Shimabukuro et al. Psychiatry and Clinical Neurosciences (2005), 59, Regular Article Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patients JIN SHIMABUKURO, md, 1 SHUICHI AWATA, md, phd 2 AND HIROO MATSUOKA, md, phd 2 1 Department of Psychiatry, Tohoku University Hospital and 2 Department of Psychiatry, Tohoku University Graduate School of Medicine, Sendai, Japan Abstract In order to clarify the characteristics of Behavioral and Psychological Symptoms of Dementia (BPSD) in patients with mild Alzheimer s disease (AD), BPSD among the severities of Clinical Dementia Rating (CDR) in 74 patients with AD were compared using the Neuropsychiatric inventory (NPI). The result, when compared between mild (CDR = 0.5, 1) and moderate or severe (CDR = 2, 3) AD, was a significant difference in frequency of euphoria, disinhibition and aberrant motor behavior, but no significant difference was found in frequency of delusions, hallucinations, agitation, dysphoria, anxiety, apathy and irritability. In addition, a significant difference was found in the mean scores of the composite score for euphoria, apathy, disinhibition and aberrant motor behavior, but no significant difference was found in the mean scores of the composite score for delusions, hallucinations, agitation, dysphoria, anxiety and irritability. That is, the mild AD groups (CDR 0.5 or 1) had delusions, hallucinations, agitation, dysphoria, anxiety, apathy and irritability as frequently as the moderate or severe AD groups (CDR 2 or 3), and had the equivalent level of composite scores to the moderate or severe AD groups (CDR 2 or 3) in delusion, hallucination, agitation, dysphoria, anxiety and irritability. Therefore, it was supposed that psychotic symptoms (delusion, hallucination) and emotional symptoms (agitation, dysphoria, anxiety, irritability) are important BPSD in patients with mild AD as well as those with moderate or severe AD, and there are needs for health, welfare and medical services for these symptoms. Key words Alzheimer s disease, Behavioral and Psychological Symptoms of Dementia, Clinical Dementia Rating, mild dementia, Neuropsychiatric Inventory. INTRODUCTION The Behavioral and Psychological Symptoms of Dementia (BPSD) 1 can significantly aggravate caregiver s distress and can be the major reason for the institutionalization of patients with Alzheimer s disease (AD). 2,3 However, adequate intervention can ameliorate the symptoms of BPSD 4 and improve the quality of life for both the patient and the caregiver. Correspondence address: Jin Shimabukuro, Department of Psychiatry, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai , Japan. cocoa-thk@umin.ac.jp Received 29 July 2004; revised 20 December 2004; accepted 25 December Thus, it is very important to develop a practical and effective strategy for the early intervention of the symptoms of BPSD in mild dementia, which may contribute to keeping the long-term patient s and caregiver s life from an undesirable stressful burden. In studies on the elderly population utilizing a community mental health consulting program, Awata 5,6 showed that patients with mild dementia had delusion, anxiety, depression, irritability or aggression as frequently as those with moderate or severe dementia, and proposed an integrated community care system for the elderly with mild dementia to address these symptoms. In the present study, we examined the characteristics of the BPSD in patients with mild AD who attended the psychiatric ward in a general hospital for
2 Dementia and mild Alzheimers 275 the first time, in order to clarify the target symptoms for early intervention in the community and clinical settings. METHODS The study subjects consisted of 74 patients with AD (male/female: 20/54; mean age ± SD: 76.0 ± 7.9; range: 53-93) and their caregivers who attended the Department of Psychiatry, Furukawa City Hospital for the first time, from April 2001 to July Diagnoses were made according to the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, 7 on the basis of complete medical history, comprehensive psychiatric, neurological, and physical examination, laboratory findings of blood, and findings in magnetic resonance imaging and single photon emission computed tomography. In the comprehensive psychiatric assessment, we evaluated the level of cognitive impairment by the Mini Mental State Examination (MMSE) 8 and severities of dementia by the Clinical Dementia Rating (CDR). 9 BPSD was evaluated by the Japanese version of the Neuropsychiatric Inventory (NPI) 10 originally developed by Cummings et al. 11 The NPI can evaluate a wider range of psychopathology, distinguish among different etiologies of dementia, differentiate behavioral changes, and minimize administration time. First, we examined 10 behavioral abnormalities (delusions, hallucinations, dysphoria, anxiety, agitation, euphoria, disinhibition, irritability, apathy, and aberrant motor activity) by calculating the numbers of positive responses to screening questions in each behavioral domain. Second, on the basis of scoring the frequency (1 through 4) and the severity (1 through 3) of each behavioral abnormality, a composite score for each domain was determined as the product of the frequency and severity subscores (maximum, 12). The total NPI score was calculated by adding all composite scores for each NPI domain. Thus, the total NPI score ranged between 0 and 120. Information regarding the NPI was obtained from caregivers who were directly caring for their demented family member. Group comparison of demographic variables, cognitive function, total NPI score and prevalence of 10 behaviors in NPI were performed using one-way anova, c 2 tests and Kruskal Wallis test, respectively. Correlation between the composite scores of each behavioral domain of NPI and the level of the CDR severity was analyzed using Spearman s correlation coefficient. Comparison between the mild AD groups and the moderate or severe AD groups were performed using c 2 tests and the Mann Whitney U-test. RESULTS Table 1 shows the subject s number, mean age, sex ratio, and the mean scores of MMSE in each CDR group. There was no significant difference in mean age and sex ratio between the CDR groups, although the score of MMSE was significantly decreased as the level of severity was increased (F = 96.7, P < 0.01). In the NPI, all subjects were shown to have scorable psychopathology. The percentages of patients having each NPI symptom in total are shown in Figure 1. The most common behavior was apathy (97.3%), followed by delusions (62.2%), irritability (59.5%), dysphoria (52.7%), anxiety (51.4%), aberrant motor behavior (47.3%), agitation (44.6%), disinhibition (31.3%), and hallucinations (25.7%). The least common behavior was euphoria (13.5%). The percentages of patients having each NPI symptom in the level of the CDR severity are shown in Table 2. The frequencies in agitation (c 2 = 9.6, P < 0.05), euphoria (c 2 = 19.5, P < 0.01) and aberrant Table 1. Subjects Number (M/F) Age (year) Mean ± SD MMSE Mean ± SD Total NPI score Mean ± SD CDR = (5/12) 72.9 ± ± ± 7.2 CDR = 1 33 (6/27) 77.0 ± ± ± 11.1 CDR = 2 17 (5/12) 77.4 ± ± ± 15.4 CDR = 3 7 (4/3) 75.9 ± ± ± 11.8 Total 74 (20/54) 76.0 ± ± ± 12.1 Total NPI score was calculated by adding all composite scores as a product of the frequency and severity subscores for each Neuropsychiatric Inventory domain. CDR, Clinical Dementia Rating; F, female; M, male; MMSE, Mini-Mental State Examination; NPI, Neuropsychiatric Inventory; SD, standard deviation.
3 276 J. Shimabukuro et al. Del n=74 Hal Agit Dys Anx Euph Apa Dis Irrit Motor % Figure 1. Prevalence of 10 behaviors in the Neuropsychiatric Inventory for all subjects. Prevalence was calculated as the frequency of patients who had a composite score more than 0. Values indicate a percentage (%). NPI, Neuropsychiatric Inventory; Del, delusions; Hal, hallucinations; Agit, agitation; Dys, dysphoria; Anx, anxiety; Euph, euphoria; Apa, apathy; Dis, disinhibition; Irrit, irritability; Motor, aberrant motor behavior. Table 2. Prevalence of 10 behaviors in the Neuropsychiatric Inventory across the Clinical Dementia Rating groups (%) Group Del Hal Agit Dys Anx Euph Apa Dis Irrit Motor CDR = CDR = CDR = CDR = Prevalence was calculated as the frequency of patients who had a composite score more than 0. Values indicate a percentage (%). Agit, agitation; Anx, anxiety; Apa, apathy; CDR, Clinical Dementia Rating; Del, delusions; Dis, disinhibition; Dys, dysphoria; Euph, euphoria; Hal, hallucinations; Irrit, irritability; Motor, aberrant motor behavior; NPI, Neuropsychiatric Inventory. motor behavior (c 2 = 18.2, P < 0.01) were significantly related to the level of CDR severity. However, other NPI symptoms were not related to the level of CDR severity. When compared between mild (CDR = 0.5, 1) and moderate or severe (CDR = 2, 3) AD, significant difference was found in frequency of euphoria (mild vs. moderate or severe, 2.0% vs. 37.5%, c 2 = 17.1, P < 0.01), disinhibition (22.0% vs. 50.0%, c 2 = 5.8, P < 0.05) and aberrant motor behavior (34.0% vs. 75.0%, c 2 = 11.3, P < 0.01), but no significant difference was found in frequency of delusions (64.0% vs. 58.3%), hallucinations (20.0% vs. 37.5%), agitation (42.0% vs. 50.0%), dysphoria (58.0% vs. 41.7%), anxiety (52.0% vs. 50.0%), apathy (96.0% vs. 100%), and irritability (60.0% vs. 58.3%). That is, the patients with AD with mild dementia (CDR 0.5 or 1) had delusions, hallucinations, agitation, dysphoria, anxiety, apathy and irritability as frequently as those with moderate or severe dementia (CDR 2 or 3). The mean (standard deviation) total NPI scores are shown in Table 1. There is significant difference in the total NPI scores between CDR groups with increasing the severity of BPSD as increasing the severity of dementia (c 2 = 8.2, P < 0.05). We demonstrate the mean scores of the NPI composite score for each behavioral domain in each CDR group in Figure 2. Composite scores in agitation (r = 0.28, P < 0.05), euphoria (r = 0.47, P < 0.01), apathy (r = 0.36, P < 0.01), disinhibition (r = 0.33, P < 0.01) and aberrant motor behavior (r = 0.49, P < 0.01) were significantly correlated with the level of CDR severity; the score was increased as the severity was increased (Table 3). However, other NPI symptoms were not correlated with the level of CDR severity. When compared between mild (CDR = 0.5, 1) and moderate or severe (CDR = 2, 3) AD, significant difference was found in the mean scores of the composite score for euphoria (mild vs. moderate or severe: 0.0 vs. 1.6,
4 Dementia and mild Alzheimers 277 Figure 2. The mean scores of the Neuropsychiatric Inventory composite score for each behavioral domain in each Clinical Dementia Rating group. A composite score for each domain was determined as the product of the frequency and severity subscores (maximum, 12). NPI, Neuropsychiatric Inventory; CDR, Clinical Dementia Rating; Del, delusions; Hal, hallucinations; Agit, agitation; Dys, dysphoria; Anx, anxiety; Euph, euphoria; Apa, apathy; Dis, disinhibition; Irrit, irritability; Motor, aberrant motor behavior. Mean Score Del Hal Agit Dys Anx Euph Apa Dis Irrit Motor CDR=0.5 CDR=1 CDR=2 CDR=3 Table 3. Correlation of Clinical Dementia Rating severity with scores of Mini-Mental State Examination, Total, and composite scores for each Neuropsychiatric Inventory domain Clinical Dementia Rating r P MMSE P < 0.01 Total P < 0.05 Del NS Hal NS Agit P < 0.05 Dys NS Anx NS Euph P < 0.01 Apa P < 0.01 Dis P < 0.01 Irrit NS Motor P < 0.01 Statistical analysis was performed using Spearman s correlation coefficient. Apa, apathy; Agit, agitation; Anx, anxiety; CDR, Clinical Dementia Rating; Del, delusions; Dis, disinhibition; Dys, dysphoria; Euph, euphoria; Hal, hallucinations; Irrit, irritability; MMSE, Mini-Mental State Examination; Motor, aberrant motor behavior; NPI, Neuropsychiatric Inventory; NS, not significant; Total, total NPI scores. U = 382.5, P < 0.01), apathy (3.7 vs. 5.5, U = 368.5, P < 0.01), disinhibition (0.5 vs. 1.6, U = 418.0, P < 0.01) and aberrant motor behavior (1.3 vs. 4.0, U = 310.5, P < 0.01), but no significant difference was found in the mean scores of the composite score for delusions (3.0 vs. 2.5), hallucinations (0.8 vs. 1.2), agitation (1.3 vs. 2.0), dysphoria (1.7 vs. 1.5), anxiety (1.8 vs. 2.1), and irritability (2.1 vs. 2.5; Table 4). That is, the mild AD groups (CDR 0.5 or 1) had the equivalent level of composite scores to the moderate or severe AD groups (CDR 2 or 3) in delusion, hallucination, agitation, dysphoria, anxiety and irritability. DISCUSSION The present study demonstrates that apathy was the most frequent behavioral change in patients with AD, followed by delusions, irritability, dysphoria, anxiety, aberrant motor behavior, agitation, disinhibition and hallucinations, and that the least common behavior was euphoria. In the previous studies using the NPI, Mega et al. 12 reported that apathy was the most frequent behavioral change in AD, followed by agitation, anxiety, irritability, dysphoria and aberrant motor behavior, and that the least common behavior was euphoria. Hirono et al. 10 demonstrated that apathy was the most frequent, followed by aberrant motor behavior, delusions, dysphoria, irritability and euphoria. Vilalta-Franch et al. 13 also found the most frequent symptom to be apathy and the least frequent symptom was euphoria in patients with dementia. However, Choi et al. 14 found the former to be apathy but the latter to be hallucination in patients with dementia. The present study reconfirms the findings that apathy is the most frequent and euphoria is the most rare BPSD in AD patients, as most previous studies have demonstrated. In addition, we found that the patients with AD with mild dementia (CDR 0.5 or 1) had delusions, hallucinations, agitation, dysphoria, anxiety, apathy and irritability as frequently as those with moderate or severe dementia (CDR 2 or 3). There is some difference in the previous finding of Cummings et al. 4 They found that
5 278 J. Shimabukuro et al. Table 4. Comparison between the mild Alzheimer s disease groups and the moderate or severe Alzheimer s disease groups in the mean scores of the composite score of the Neuropsychiatric Inventory Mild AD groups (CDR = 0.5, 1) Moderate or severe AD groups (CDR = 2, 3) Mann-Whitney U-test Number (M/F) (11/39) (9/15) Del 3.0 ± ± 3.1 NS Hal 0.8 ± ± 2.1 NS Agit 1.3 ± ± 2.7 NS Dys 1.7 ± ± 2.1 NS Anx 1.8 ± ± 2.6 NS Euph 0.0 ± ± 2.5 P < 0.01 Apa 3.7 ± ± 2.6 P < 0.01 Dis 0.5 ± ± 2.2 P < 0.01 Irrit 2.1 ± ± 2.7 NS Motor 1.3 ± ± 3.4 P < 0.01 Statistical analysis was performed using Mann Whitney U-test. Values are presented as mean ± standard deviation. Agit, agitation; Anx, anxiety; Apa, apathy; Del, delusions; Dis, disinhibition; Dys, dysphoria; Euph, euphoria; F, female; Hal, hallucinations; Irrit, irritability; M, male; Motor, aberrant motor behavior; NS, not significant; NPI, Neuropsychiatric Inventory. the frequencies of agitation, dysphoria, anxiety, apathy and aberrant motor behavior were increased with the level of dementia severity defined by the MMSE. The difference in the sampling method may contribute to the difference in the prevalence of BPSD. The sample of Cummings et al. included non-ad patients whereas our sample was exclusively AD patients who attended the psychiatric ward in a general hospital for the first time. The total NPI scores were significantly increased with the level of CDR severity. This finding is consistent with that of Mega et al., 12 who found that the total NPI scores were significantly increased with the level of severity of dementia determined by the score of MMSE. In the present study, however, the composite scores of each behavioral domain showed a different pattern between the mild AD groups (CDR 0.5 or 1) and the moderate or severe AD groups (CDR 2 or 3). The composite scores of euphoria, apathy, disinhibition and aberrant motor behavior in the mild AD groups (CDR 0.5 or 1) were significantly lower than those in the moderate or severe AD groups (CDR 2 or 3). However, there was no significant difference in the composite score of delusions, hallucinations, agitation, dysphoria, anxiety and irritability. That is, the mild AD groups (CDR 0.5 or 1) had the equivalent level of composite scores to the moderate or severe AD groups (CDR 2 or 3) in delusion, hallucination, agitation, dysphoria, anxiety and irritability. Finally, when compared between mild (CDR = 0.5, 1) and moderate or severe (CDR = 2, 3) AD, we found that in the frequency of NPI, the mild AD groups (CDR 0.5 or 1) had delusions, hallucinations, agitation, dysphoria, anxiety, apathy and irritability as frequently as the moderate or severe AD groups (CDR 2 or 3), and in the composite scores of NPI, the mild AD groups (CDR 0.5 or 1) had the equivalent level of composite scores to the moderate or severe AD groups (CDR 2 or 3) in delusion, hallucination, agitation, dysphoria, anxiety and irritability. This finding indicates that psychotic symptoms (delusion and hallucination) and emotional symptoms (agitation, dysphoria, anxiety, irritability) may be the crucial BPSD in patients with mild AD as well as those with moderate or severe AD. These symptoms might be the target BPSD, for which it is urgently needed to develop the strategies of early intervention in the community and clinical settings. REFERENCES 1. Finkel SI, de Silva C, Cohen G et al. Behavioral and Psychological Signs and Symptoms of Dementia; A consensus statement on current knowledge and implications for research and treatment. Int. Psychogeriatr. 1996; 8: Pruchno RA, Michaels JE. Predictors of institutionalization among Alzheimer victims with caregiving spouses. J. Gerontol. 1990; 45: S259 S Steele C, Rovner B, Chase GA et al. Psychiatric symptoms and nursing home placement of patients with Alzheimer s disease. Am. J. Psychiatry 1990; 147:
6 Dementia and mild Alzheimers Cummings JL. The neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology 1997; 48: S10 S Awata S. A practical study on the early diagnosis and early care system for the elderly with dementia living in depopulated regions (1). A network system of public mental health services connected with local general hospital in northwestern Miyagi. Jpn J. Geriatr. Psychiatry 1999; 10: (in Japanese with English abstract). 6. Awata S. A practical study on the early diagnosis and early care system for the elderly with dementia living in depopulated regions (2). An integrated model including a psychiatric consultation program and the community mental health team. Jpn J. Geriatr. Psychiatry 2002; 13: (in Japanese with English abstract). 7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Press, Washington, DC, Folstein MF, Folstein SE, Mchugh PR et al. Mini-Mental State ; A practical method for grading the cognitive state for the clinician. J. Psychiatr. Res. 1975; 12: Hughes CP, Berg L, Danziger WL et al. A new clinical scale for the staging of dementia. Br. J. Psychiatry 1982; 140: Nobutsugu H, Etsuro M, Yoshitaka I et al. The Japanese version of Neuropsychiatric Inventory. No Shinkei 1997; 49: (in Japanese with English abstract). 11. Cummings JL, Mega M, Gray K et al. The Neuropsychiatric Inventory; comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: Mega MS, Cummings JL, Fiorello T et al. The spectrum of behavioral changes in Alzheimer s disease. Neurology 1996; 46: Vilalta-Franch J, Lozano-Gallego M, Hernandez-Ferrandiz M et al. The Neuropsychiatric Inventory; Psychometric properties of its adaptation into Spanish. Rev. Neurol. 1999; 29: Choi SH, Na DL, Kwon HM et al. The Korean version of the neuropsychiatric inventory; a scoring tool for neuropsychiatric disturbance in dementia patients. J. Korean Med. Sci. 2000; 15:
Reliability of the Brazilian Portuguese version of the Neuropsychiatric Inventory (NPI) for patients with Alzheimer s disease and their caregivers
International Psychogeriatrics (2008), 20:2, 383 393 C 2007 International Psychogeriatric Association doi:10.1017/s1041610207006254 Printed in the United Kingdom Reliability of the Brazilian Portuguese
More informationScreening and Management of Behavioral and Psychiatric Symptoms Associated with Dementia
Screening and Management of Behavioral and Psychiatric Symptoms Associated with Dementia Measure Description Percentage of patients with dementia for whom there was a documented screening* for behavioral
More informationResponsiveness of the QUALID to Improved Neuropsychiatric Symptoms in Patients with Alzheimer s Disease
ORIGINAL RESEARCH Responsiveness of the QUALID to Improved Neuropsychiatric Symptoms in Patients with Alzheimer s Disease Hadas Benhabib 1, Krista L. Lanctôt, PhD 1,2,4, Goran M. Eryavec, MD, FRCPC 3,4,
More informationN europsychiatric symptoms can induce marked disability
PAPER Neuropsychiatric profiles in patients with Alzheimer s disease and vascular dementia J-L Fuh, S-J Wang, J L Cummings... See end of article for authors affiliations... Correspondence to: Dr J-L Fuh,
More informationRange of neuropsychiatric disturbances in patients with Parkinson s disease
492 Section of Geriatric Psychiatry, Rogaland Psychiatric Hospital D Aarsland N G Lim C Janvin Department of Neurology, Central Hospital of Rogaland, Stavanger, Norway J P Larsen K Karlsen E Tandberg Departments
More informationSeverity and prevalence of behavioral and psychological symptoms among patients of different dementia stages in Taiwan
Original article Severity and prevalence of behavioral and psychological symptoms among patients of different dementia stages in Taiwan Si-Sheng Huang 1, Wen-Fu Wang 2, Yi-Cheng Liao 1 1 Department of
More informationCHAPTER 5 NEUROPSYCHOLOGICAL PROFILE OF ALZHEIMER S DISEASE
CHAPTER 5 NEUROPSYCHOLOGICAL PROFILE OF ALZHEIMER S DISEASE 5.1 GENERAL BACKGROUND Neuropsychological assessment plays a crucial role in the assessment of cognitive decline in older age. In India, there
More informationDEMENTIA WITH LEWY bodies (DLB) is the
Psychiatry and Clinical Neurosciences 2017; 71: 409 416 doi:10.1111/pcn.12511 Regular Article Association of premorbid personality with behavioral and psychological symptoms in dementia with Lewy bodies:
More informationNEUROPSYCHOMETRIC TESTS
NEUROPSYCHOMETRIC TESTS CAMCOG It is the Cognitive section of Cambridge Examination for Mental Disorders of the Elderly (CAMDEX) The measure assesses orientation, language, memory, praxis, attention, abstract
More informationPsychiatric Morbidity in Dementia Patients in a Neurology-Based Memory Clinic
Original Articles 179 Psychiatric Morbidity in Dementia Patients in a Neurology-Based Memory Clinic Ching-Sen Shih 1, Sui-Hing Yan 2, Ying-Hoo Ho 1, Yuh-Te Lin 1, Jie-Yuan Li 1, and Yuk-Keung Lo 1 Abstract-
More informationThe course of neuropsychiatric symptoms in dementia. Part II: relationships among behavioural sub-syndromes and the influence of clinical variables
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY Int J Geriatr Psychiatry 2005; 20: 531 536. Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/gps.1317 The course of neuropsychiatric
More informationDementia is a common neuropsychiatric disorder characterized by progressive impairment of
Focused Issue of This Month Diagnosis and Treatment for Behavioral and Psychological Symptoms of Dementia Byoung Hoon Oh, MD Department of Psychiatry, Yonsei University College of Medicine E - mail : drobh@yuhs.ac
More informationGerardo Machnicki 1, Ricardo F. Allegri 1,2 *, Carol Dillon 1, Cecilia M. Serrano 1,2 and Fernando E Taragano 2 SUMMARY INTRODUCTION
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY Int J Geriatr Psychiatry (2008) Published online in Wiley InterScience (www.interscience.wiley.com).2133 Cognitive, functional and behavioral factors associated
More informationQUESTIONNAIRE: Finland
QUESTIONNAIRE: Finland To put the assessment and management of behavioural disorders into a broader context of social and health policy and services in Finland, some background information is presented.
More informationDownloaded from irje.tums.ac.ir at 9:18 IRDT on Saturday September 15th 2018
.5159 :2 7 1390 : 88989123 4 3 2 1 1 : 2 3 4. :. :. 84 : Burden Iranian Version of Caregiver.. Neuropsychiatric Inventory ().. 85. 2/4 39/3 : ebrahemen@gmail.com : 89/10/4 : 89/8/26: :. : 40 (116 58).
More informationNeuropsychiatric Manifestations in Vascular Cognitive Impairment Patients with and without Dementia
86 Neuropsychiatric Manifestations in Vascular Cognitive Impairment Patients with and without Dementia Pai-Yi Chiu 1,3, Chung-Hsiang Liu 2, and Chon-Haw Tsai 2 Abstract- Background: Neuropsychiatric profile
More information. Neuropsychiatric Inventory (NPI) :
Downloaded Downloaded from http://journals.tums.ac.ir/ from irje.tums.ac.ir at 9:18 on IRDT Monday, Saturday February September 27, 2012 15th 2018.5159 :2 7 1390 : 88989123 4 3 2 1 1 : 2 3 4. :. :. 84
More informationABSTRACT INTRODUCTION
Neurol Ther (2018) 7:333 340 https://doi.org/10.1007/s40120-018-0109-9 ORIGINAL RESEARCH Decreased Behavioral Abnormalities After Treatment with Combined Donepezil and Yokukansankachimpihange in Alzheimer
More informationThe place for treatments of associated neuropsychiatric and other symptoms
The place for treatments of associated neuropsychiatric and other symptoms Luca Pani dg@aifa.gov.it London, 25 th November 2014 Workshop on Alzheimer s Disease European Medicines Agency London, UK Public
More informationNeuropsychiatric Inventory Nursing Home Version (NPI-NH)
This is a Sample version of the Neuropsychiatric Inventory Nursing Home Version (NPI-NH) The full version of the Neuropsychiatric Inventory Nursing Home Version (NPI-NH) comes without sample watermark..
More informationComment on administration and scoring of the Neuropsychiatric Inventory in clinical trials
Alzheimer s & Dementia 4 (2008) 390 394 Comment on administration and scoring of the Neuropsychiatric Inventory in clinical trials Donald J. Connor a, *, Marwan N. Sabbagh a, Jeffery L. Cummings b a Cleo
More informationParkinsonian Disorders with Dementia
Parkinsonian Disorders with Dementia George Tadros Consultant in Old Age Liaison Psychiatry, RAID, Heartlands Hospital Professor of Dementia and Liaison Psychiatry, Aston Medical School Aston University
More informationBehavioral and Psychologic Symptoms in Different Types of Dementia
ORIGINAL ARTICLE Behavioral and Psychologic Symptoms in Different Types of Dementia Ming-Jang Chiu,* Ta-Fu Chen, Ping-Keung Yip, Mau-Sun Hua, 1 Li-Yu Tang 2 Background/Purpose: Behavioral and psychologic
More informationCaregiver Burden In Dementia: A Study In The Turkish Population
ISPUB.COM The Internet Journal of Neurology Volume 4 Number 2 Caregiver Burden In Dementia: A Study In The Turkish Population G Karlikaya, G Yukse, F Varlibas, H Tireli Citation G Karlikaya, G Yukse, F
More informationValidation of apathy evaluation scale and assessment of severity of apathy in Alzheimer s diseasepcn_
Psychiatry and Clinical Neurosciences 2012; 66: 227 234 doi:10.1111/j.1440-1819.2011.02315.x Regular Article Validation of apathy evaluation scale and assessment of severity of apathy in Alzheimer s diseasepcn_2315
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #283: Dementia Associated Behavioral and Psychiatric Symptoms Screening and Management National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY
More informationBurden of behavioral and psychiatric symptoms in people screened positive for dementia in primary care results of the DelpHi-study René Thyrian
Burden of behavioral and psychiatric symptoms in people screened positive for dementia in primary care results of the DelpHi-study René Thyrian German Center for Neurodegenerative Diseases (DZNE), site
More informationResearch Article Behavioural and Psychological Symptoms in Poststroke Vascular Cognitive Impairment
Behavioural Neurology, Article ID 430128, 5 pages http://dx.doi.org/10.1155/2014/430128 Research Article Behavioural and Psychological Symptoms in Poststroke Vascular Cognitive Impairment Meena Gupta,
More informationPDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a preprint version which may differ from the publisher's version. For additional information about this
More informationORIGINAL CONTRIBUTION. The Spectrum of Behavioral Responses to Cholinesterase Inhibitor Therapy in Alzheimer Disease
ORIGINAL CONTRIBUTION The Spectrum of Behavioral Responses to Cholinesterase Inhibitor Therapy in Alzheimer Disease Michael S. Mega, MD, PhD; Donna M. Masterman, MD; Susan M. O Connor, RNC; Terry R. Barclay,
More informationPsychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD
Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias Aaron H. Kaufman, MD Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias Aaron H. Kaufman, M.D. Health Sciences
More informationIT IS WELL known that individuals with dementia. Classifying eating-related problems among institutionalized people with dementia.
doi:10.1111/pcn.12375 Regular Article Classifying eating-related problems among institutionalized people with dementia Shunichiro Shinagawa, MD, PhD, 1 * Kazuki Honda, MD, PhD, 2 Tetsuo Kashibayashi, MD,
More informationResearch Article Sex Differences in Neuropsychiatric Symptoms of Alzheimer s Disease: The Modifying Effect of Apolipoprotein E ε4 Status
Behavioural Neurology Volume 2015, Article ID 275256, 6 pages http://dx.doi.org/10.1155/2015/275256 Research Article Sex Differences in Neuropsychiatric Symptoms of Alzheimer s Disease: The Modifying Effect
More informationClinical Characteristics of Behavioral and Psychological Symptoms in Patients with Drug-naïve Alzheimer s Disease
Dementia and Neurocognitive Disorders 2012; 11: 87-94 ORIGINAL ARTICLE Clinical Characteristics of Behavioral and Psychological Symptoms in Patients with Drug-naïve Alzheimer s Disease Yong Tae Kwak, M.D.,
More informationAlzheimer's Disease An update on diagnostic criteria & Neuropsychiatric symptoms. l The diagnosis of AD l Neuropsychiatric symptoms l Place of the ICT
Alzheimer's Disease An update on diagnostic criteria & Neuropsychiatric symptoms State of the art lecture March 4-2012 Philippe H Robert, Philippe Nice - France Robert The diagnosis of AD Neuropsychiatric
More informationBehavioural disturbances in dementia patients and quality of the marital relationship
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY Int J Geriatr Psychiatry 2003; 18: 149 154. Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/gps.807 Behavioural disturbances
More informationMissing Data Analysis in Drug-Naïve Alzheimer s Disease with Behavioral and Psychological Symptoms
Original Article http://dx.doi.org/10.3349/ymj.2013.54.4.825 pissn: 0513-5796, eissn: 1976-2437 Yonsei Med J 54(4):825-831, 2013 Missing Data Analysis in Drug-Naïve Alzheimer s Disease with Behavioral
More informationCLUSTERING OF BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA (BPSD): A EUROPEAN ALZHEIMER S DISEASE IN CONSORTIUM (EADC) STUDY
426 Original articles CLUSTERING OF BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA (BPSD): A EUROPEAN ALZHEIMER S DISEASE IN CONSORTIUM (EADC) STUDY M. Petrovic 1,2, C. Hurt 2, D. Collins 2, A. Burns
More informationNumber of Items. Response Categories. Part V: Specific Behavior Scales-Sleep Scales. Based on past month
Part V: Specific Behavior Scales-Sleep Scales Based on past month First 4 items ask for time or amount of sleep 41. Pittsburgh Sleep Quality Index (PSQI) Sleep quality Sleep latency Sleep duration Habitual
More informationNeuroPharmac Journal ISSN: Alzheimer s Disease: Pharmacotherapy of noncognitive symptoms Aslam Pathan; Abdulrahman M.
ISSNISSN ISSN: 2456-3927 NeuroPharmac Journal Alzheimer s Disease: Pharmacotherapy of noncognitive symptoms Aslam Pathan; Abdulrahman M. Alshahrani www. neuropharmac.com Jan-April 2018, Volume 3, Issue
More informationDEMENTIA MEASURES GROUP OVERVIEW
DEMENTIA MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: 2015 PQRS MEASURES IN DEMENTIA MEASURES GROUP: #47 Care Plan #280 Dementia: Staging of Dementia #281 Dementia: Cognitive Assessment
More informationEstimating the Validity of the Korean Version of Expanded Clinical Dementia Rating (CDR) Scale
Estimating the Validity of the Korean Version of Expanded Clinical Dementia Rating (CDR) Scale Seong Hye Choi, M.D.*, Duk L. Na, M.D., Byung Hwa Lee, M.A., Dong-Seog Hahm, M.D., Jee Hyang Jeong, M.D.,
More informationSupplementary Online Content
Supplementary Online Content Atri A, Frölich L, Ballard C, et al. Effect of idalopirdine as adjunct to cholinesterase inhibitors on in cognition in patients with Alzheimer disease: three randomized clinical
More informationNeuropsychiatric symptoms in people screened positive for dementia in primary care
International Psychogeriatrics (2015), 27:1, 39 48 C International Psychogeriatric Association 2014 doi:10.1017/s1041610214001987 Neuropsychiatric symptoms in people screened positive for dementia in primary
More informationManagement of the Acutely Agitated Long Term Care Patient
Management of the Acutely Agitated Long Term Care Patient 80 60 Graying of the Population US Population Over Age 65 Millions of Persons 40 20 0 1900 1920 1940 1960 1980 1990 2010 2030 Year Defining Dementia
More informationEffects of short-term reminiscence therapy on elderly with dementia: A comparison with everyday conversation approaches
doi:./j.79-8.8.6.x PSYCHOGERIATRICS 8; 8: ORIGINAL ARTICLE Effects of short-term reminiscence therapy on elderly with dementia: A comparison with everyday conversation approaches Yumiko OKUMURA,, Satoshi
More informationNeuropsychiatric Syndromes
Neuropsychiatric Syndromes Susan Czapiewski,MD VAHCS December 10, 2015 Dr. Czapiewski has indicated no potential conflict of interest to this presentation. She does intend to discuss the off-label use
More informationBehavioural Problems and Patterns of Psychopharmacological Treatment given in Elderly Patients with Dementia
The International Journal of Indian Psychology ISSN 2348-5396 (e) ISSN: 2349-3429 (p) Volume 6, Issue 4, DIP: 18.01.090/20180604 DOI: 10.25215/0604.090 http://www.ijip.in October-December, 2018 Research
More informationNeuropsychiatric disturbances such as delusions,
Differential Neuropsychiatric Responses to Tacrine in Alzheimer s Disease: Relationship to Dementia Severity Daniel Kaufer, M.D. Jeffrey L. Cummings, M.D. Dianne Christine, R.N. Neuropsychiatric symptom
More informationScreening for Normal Cognition, Mild Cognitive Impairment, and Dementia with the Korean Dementia Screening Questionnaire
ORIGINAL ARTICLE https://doi.org/10.30773/pi.2017.08.24 Print ISSN 1738-3684 / On-line ISSN 1976-36 OPEN ACCESS Screening for Normal Cognition, Mild Cognitive Impairment, and Dementia with the Korean Dementia
More informationDysphoric symptoms in relation to other behavioral and psychological symptoms of dementia, among elderly in nursing homes
Lindbo et al. BMC Geriatrics (2017) 17:206 DOI 10.1186/s12877-017-0603-4 RESEARCH ARTICLE Open Access Dysphoric symptoms in relation to other behavioral and psychological symptoms of dementia, among elderly
More informationCity, University of London Institutional Repository
City Research Online City, University of London Institutional Repository Citation: Hurt, C. S., Banerjee, S., Tunnard, C., Whitehead, D. L., Tsolaki, M., Mecocci, P., Kloszewska, I., Soininen, H., Vellas,
More informationBehavioral and Psychological Symptoms of Dementia
Behavioral and Psychological Symptoms of Dementia Akarachaid Pinidbunjerdkool MD*, Sansanee Saengwanitch MD*, Pasiri Sithinamsuwan MD* * Division of Neurology, Department of Medicine, Phramongkutklao Hospital
More informationPractice Concepts. Copyright 2006 by The Gerontological Society of America
Practice Concepts The Gerontologist Vol. 46, No. 6, 827 832 Copyright 2006 by The Gerontological Society of America Project CARE: A Randomized Controlled Trial of a Behavioral Intervention Group for Alzheimer
More informationEffect of neuropsychiatric symptoms of Alzheimer's disease on Chinese and American caregivers
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY Int J Geriatr Psychiatry 2002; 17: 29±34. DOI: 10.1002/gps.510 Effect of neuropsychiatric symptoms of Alzheimer's disease on Chinese and American caregivers
More informationIntroduction to Dementia: Complications
Introduction to Dementia: Complications Created in March 2005 Duration: about 15 minutes Axel Juan, MD The Geriatrics Institute axel.juan@med.va.gov 305-575-3388 Credits Principal medical contributor:
More informationKingston Caregiver Stress Scale
Kingston Caregiver Stress Scale ADMINISTRATION AND INTERPRETATION MANUAL Seniors Mental Health Program, Providence Care Mental Health Services Kingston, Canada K7L 4X3 The Kingston Scales and Manuals can
More informationDEMENTIA MEASURES GROUP OVERVIEW
2014 PQRS OPTIONS F MEASURES GROUPS: DEMENTIA MEASURES GROUP OVERVIEW 2014 PQRS MEASURES IN DEMENTIA MEASURES GROUP: #280. Dementia: Staging of Dementia #281. Dementia: Cognitive Assessment #282. Dementia:
More informationCorrespondence should be addressed to Shunichiro Shinagawa;
International Alzheimer s Disease Volume 013, Article ID 16919, 6 pages http://dx.doi.org/10.55/013/16919 Research Article Longitudinal Changes in the Government-Certified Index Stage and Requisite Costs
More informationSupplementary Online Content
Supplementary Online Content Porsteinsson AP, Drye LT, Pollock BG, et al. Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized controlled trial. JAMA. doi:10.1001/jama.2014.93 eappendix.
More informationAcetylcholinesterase inhibitors: donepezil, rivastigmine, tacrine or galantamine for non-alzheimer s dementia
STEER 2002; Vol 2: No.2 Acetylcholinesterase inhibitors: donepezil, rivastigmine, tacrine or galantamine for non-alzheimer s dementia Bunmi Fajemisin Evidence search date: November 2001 www.signpoststeer.org
More informationThe efficacy of Rivastigmine in the management of the behavioral and psychological symptoms of lewy body dementia- a review of literature
Review article: The efficacy of Rivastigmine in the management of the behavioral and psychological symptoms of lewy body dementia- a review of literature Dr. Ivan Netto 1, Aditya Iyer 2, Dr. Prathamesh
More informationNeuropsychiatric Symptoms and Syndromes in a Large Cohort of Newly Diagnosed, Untreated Patients With Alzheimer Disease
Neuropsychiatric Symptoms and Syndromes in a Large Cohort of Newly Diagnosed, Untreated Patients With Alzheimer Disease Gianfranco Spalletta, M.D., Ph.D., Massimo Musicco, M.D., Alesandro Padovani, M.D.,
More informationAnosognosia, or loss of insight into one s cognitive
REGULAR ARTICLES Anosognosia Is a Significant Predictor of Apathy in Alzheimer s Disease Sergio E. Starkstein, M.D., Ph.D. Simone Brockman, M.A. David Bruce, M.D. Gustavo Petracca, M.D. Anosognosia and
More informationQuantitative analysis for a cube copying test
86 99 103 2010 Original Paper Quantitative analysis for a cube copying test Ichiro Shimoyama 1), Yumi Asano 2), Atsushi Murata 2) Naokatsu Saeki 3) and Ryohei Shimizu 4) Received September 29, 2009, Accepted
More informationUDS Progress Report. -Standardization and Training Meeting 11/18/05, Chicago. -Data Managers Meeting 1/20/06, Chicago
UDS Progress Report -Standardization and Training Meeting 11/18/05, Chicago -Data Managers Meeting 1/20/06, Chicago -Training material available: Gold standard UDS informant and participant interviews
More informationThe Neuropsychiatric Inventory Questionnaire: Background and Administration
The Neuropsychiatric Inventory Questionnaire: Background and Administration The Neuropsychiatric Inventory Questionnaire (NPI-Q) was developed and crossvalidated with the standard NPI to provide a brief
More informationWorldwide, over 40 million people have. Pimavanserin in Alzheimer s Disease Psychosis: Efficacy in Patients with More Pronounced Psychotic Symptoms
The Journal of Prevention of Alzheimer s Disease - JPAD Volume 6, Number 1, 2019 Original Research The Author(s) Pimavanserin in Alzheimer s Disease Psychosis: Efficacy in Patients with More Pronounced
More informationThe Reliability and Validity of the Korean Instrumental Activities of Daily Living (K-IADL)
The Reliability and Validity of the Korean Instrumental Activities of Daily Living (K-IADL Sue J. Kang, M.S., Seong Hye Choi, M.D.*, Byung H. Lee, M.A., Jay C. Kwon, M.D., Duk L. Na, M.D., Seol-Heui Han
More informationNEXT-Link DEMENTIA. A network of Danish memory clinics YOUR CLINICAL RESEARCH PARTNER WITHIN ALZHEIMER S DISEASE AND OTHER DEMENTIA DISEASES.
NEXT-Link DEMENTIA A network of Danish memory clinics YOUR CLINICAL RESEARCH PARTNER WITHIN ALZHEIMER S DISEASE AND OTHER DEMENTIA DISEASES. NEXT-Link DEMENTIA NEXT-Link DEMENTIA is a network of Danish
More informationIntroduction. original article. Camilla Callegari Ivano Caselli Marta Ielmini Simone Vender E-bPC
original article Camilla Callegari Ivano Caselli Marta Ielmini Simone Vender Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Insubria, Varese, Italy Influence of
More informationKingston Caregiver Stress Scale
1 Kingston Caregiver Stress Scale ADMINISTRATION AND INTERPRETATION MANUAL The Kingston Scales and Manuals can be freely downloaded from: www.kingstonscales.org Caregiver Stress or email: kscales@queensu.ca
More informationConfusional state. Digit Span. Mini Mental State Examination MMSE. confusional state MRI
10 304 29 3 confusional state MRI 29 3 304 311 2009 Key Words memory test attention brain region causative disease subcortical dementia 1 Confusional state Digit Span 1 1 5 4 Mini Mental State Examination
More informationTitle. CitationAustralasian Journal on Ageing, 31(3): Issue Date Doc URL. Rights. Type. File Information
Title Randomised controlled pilot study in Japan comparing with a home visit with conversation alone Ukawa, Shigekazu; Yuasa, Motoyuki; Ikeno, Tamiko; Yo Author(s) Kishi, Reiko CitationAustralasian Journal
More informationCIC Edizioni Internazionali
Driving habits in patients with dementia: a report from Alzheimer s disease assessment units in northern Italy Marco Mauri, MD a Elena Sinforiani, MD b Maria Giovanna Cuzzoni, MD a Giorgio Bono, MD a Chiara
More information9/24/2012. Amer M Burhan, MBChB, FRCP(C)
Depression and Dementia Amer M Burhan MBChB, FRCPC Head of CAMH Memory Clinic, Toronto Geriatric Neuropsychiatrist Assistant Prof Psychiatry at U of T Objectives Discuss the prevalence and impact of depression
More informationTorstein F. Habiger, 1 Elisabeth Flo, 1 Wilco P. Achterberg, 2 and Bettina S. Husebo 1,3. 1. Introduction
Behavioural Neurology Volume 16, Article ID 7361, 8 pages http://dx.doi.org/1.11/16/7361 Clinical Study The Interactive Relationship between Pain, Psychosis, and Agitation in People with Dementia: Results
More informationMental and Behavioral Disturbances in Dementia: Findings from the Cache County Study on Memory in Aging
Utah State University DigitalCommons@USU Psychology Faculty Publications Psychology 2000 Mental and Behavioral Disturbances in : Findings from the Cache County Study on Memory in Aging Constantine G. Lyketsos
More informationLU:research Institutional Repository of Lund University
LU:research Institutional Repository of Lund University This is an author produced version of a paper published in Alzheimer disease and associated disorders. This paper has been peer-reviewed but does
More informationNeuropsychiatric Symptoms of Patients With Progressive Supranuclear Palsy and Parkinson s Disease
Neuropsychiatric Symptoms of Patients With Progressive Supranuclear Palsy and Parkinson s Disease Dag Aarsland, M.D., Ph.D. Irene Litvan, M.D. Jan P. Larsen, M.D., Ph.D. Neuropsychiatric symptoms are common
More informationWhite matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration
White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration Annual Scientific Meeting Canadian Geriatric Society Philippe Desmarais,
More informationDEMENTIA MEASURES GROUP OVERVIEW
2016 PQRS OPTIONS F MEASURES GROUPS: DEMENTIA MEASURES GROUP OVERVIEW 2016 PQRS MEASURES IN DEMENTIA MEASURES GROUP: #47 Care Plan #134 Preventive Care and Screening: Screening for Clinical Depression
More informationPsychosis and Agitation in Dementia
Psychosis and Agitation in Dementia Dilip V. Jeste, MD Estelle & Edgar Levi Chair in Aging, Director, Stein Institute for Research on Aging, Distinguished Professor of Psychiatry & Neurosciences, University
More informationPREVALENCE AND CORRELATES OF ANXIETY IN ALZHEIMER S DISEASE
166 Chemerinski et al. DEPRESSION AND ANXIETY 7:166 170 (1998) PREVALENCE AND CORRELATES OF ANXIETY IN ALZHEIMER S DISEASE Erán Chemerinski, M.D., 1 * Gustavo Petracca, M.D., 1 Facundo Manes, M.D., 2 Ramón
More informationNIH Public Access Author Manuscript Dement Geriatr Cogn Disord. Author manuscript; available in PMC 2013 August 28.
NIH Public Access Author Manuscript Published in final edited form as: Dement Geriatr Cogn Disord. 2012 ; 34(2): 96 111. doi:10.1159/000342119. Neuropsychiatric symptoms and global functional impairment
More informationA wide range of neuropsychiatric disturbances commonly
36 PAPER Neuropsychiatric symptoms in patients with Parkinson s disease and dementia: frequency, profile and associated care giver stress D Aarsland, K Brønnick, U Ehrt, P P De Deyn, S Tekin, M Emre, J
More informationAddressing Difficult Behaviors in Dementia
Addressing Difficult Behaviors in Dementia GEORGE SCHOEPHOERSTER, MD GERIATRICIAN GENEVIVE/CENTRACARE CLINIC Objectives By the end of the session, you will be able to: 1) Explain the role of pain management
More informationCarers for older people with co-morbid cognitive impairment in general hospital: characteristics and psychological well-being
RESEARCH ARTICLE Carers for older people with co-morbid cognitive impairment in general hospital: characteristics and psychological well-being Lucy E. Bradshaw 1,2, Sarah E. Goldberg 2, Justine M. Schneider
More informationGrouping of behavioural and psychological symptoms of dementia
REVIEW ARTICLE Grouping of behavioural and psychological symptoms of dementia Rianne M. van der Linde 1, Tom Dening 2, Fiona E. Matthews 1 and Carol Brayne 1 1 Institute of Public Health, University of
More informationFactors related to Caregiver Burden in Caregivers of Patients with Parkinson s disease in Mumbai, India.
The International Journal of Indian Psychology ISSN 2348-5396 Volume 2, Issue 1, Paper ID: B00231V2I12014 http://www.ijip.in Oct to Dec 2014 Factors related to Caregiver Burden in Caregivers of Patients
More informationAssessing and Treating Agitation Associated with Alzheimer s Disease
AXS-05 R&D Day April 24, 2018 Assessing and Treating Agitation Associated with Alzheimer s Disease Marc E. Agronin, MD VP, Behavioral Health and Clinical Research, Miami Jewish Health Affiliate Associate
More informationDisclosure. Speaker Bureaus. Grant Support. Pfizer Forest Norvartis. Pan American Health Organization/WHO NIA HRSA
Disclosure Speaker Bureaus Pfizer Forest Norvartis Grant Support Pan American Health Organization/WHO NIA HRSA How Common is Psychosis in Alzheimer s Disease? Review of 55 studies 41% of those with Alzheimer
More informationRecognition and Management of Behavioral Disturbances in Dementia
Recognition and Management of Behavioral Disturbances in Dementia Danielle Hansen, DO, MS (Med Ed), MHSA INTRODUCTION 80% 90% of patients with dementia develop at least one behavioral disturbances or psychotic
More informationDEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.
DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. Introduction. Parkinson's disease (PD) has been considered largely as a motor disorder. It has been increasingly recognized that
More informationDevelopment of a Short Version of the Apathy Evaluation Scale Specifically Adapted for Demented Nursing Home Residents
Development of a Short Version of the Apathy Evaluation Scale Specifically Adapted for Demented Nursing Home Residents Ulrike Lueken, Ph.D., Ulrich Seidl, M.D., Lena Völker, Cand.Med., Elisabeth Schweiger,
More informationRoyal Free and University College Medical School, Department of Mental Health Sciences, University College London, London, England 2
PSYCHOGERIATRIA POLSKA 2004;1(3),175-184 artyku³ oryginalny original article The relationships between neuropsychiatric symptoms, cognitive deficit and prescription of psychotropics in Alzheimer s Disease:
More informationMild Cognitive Impairment (MCI)
October 19, 2018 Mild Cognitive Impairment (MCI) Yonas E. Geda, MD, MSc Professor of Neurology and Psychiatry Consultant, Departments of Psychiatry & Psychology, and Neurology Mayo Clinic College of Medicine
More informationFROM THE ALZHEIMER S ASSOCIATION INTERNATIONAL CONFERENCE 2018 NEW RESEARCH FOCUSES ON TREATING NON-COGNITIVE SYMPTOMS OF PEOPLE WITH DEMENTIA
CONTACT: Alzheimer s Association AAIC Press Office, 312-949-8710, aaicmedia@alz.org Niles Frantz, Alzheimer s Association, 312-335-5777, niles.frantz@alz.org FROM THE ALZHEIMER S ASSOCIATION INTERNATIONAL
More informationNeuropsychiatric symptoms in patients with vascular
Research Article DOI: 10.1515/tnsci-2015-0015 Translational Neuroscience 6 2015 157-161 Translational Neuroscience Neuropsychiatric symptoms in patients with vascular dementia in mainland China Abstract
More informationResearch Article Gender Differences in Dementia Spousal Caregiving
International Alzheimer s Disease Volume 2012, Article ID 162960, 5 pages doi:10.1155/2012/162960 Research Article Gender Differences in Dementia Spousal Caregiving Minna Maria Pöysti, 1 Marja-Liisa Laakkonen,
More information